Protective Potential of Montelukast Against Hepatic Ischemia/Reperfusion Injury in Rats

Journal of Surgical Research

Volumn 159, Issue 1, 2010, Pages 588-594

  Özkan, Erkan ^a   Yardimci, Samet ^a   Dulundu, Ender ^a   Topaloǧlu, Ümit ^a   Şehirli, Özer ^b   Ercan, Feriha ^c   Velioǧlu Öǧünç, Ayliz ^d   Şener, Göksel ^b  

^a HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b School of Pharmacy   (Turkey)

^c MARMARA UNIVERSITY   (Turkey)

^d Vocational School of Health Related Professions   (Turkey)

Author keywords

cytokines; ischemia reperfusion; leukotrienes; liver; montelukast; myeloperoxidase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTATHIONE; INTERLEUKIN 1BETA; LACTATE DEHYDROGENASE; LUCIGENIN; LUMINOL; MALONALDEHYDE; MONTELUKAST; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEPATIC ARTERY; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER FUNCTION; LIVER ISCHEMIA; MALE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ACETATES; ANIMALS; CYTOKINES; GLUTATHIONE; LEUKOTRIENE ANTAGONISTS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MALONDIALDEHYDE; PEROXIDASE; QUINOLINES; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 77849231201     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.08.006     Document Type: Article

References (44)

1. Glantzounis G.K., Salacinski H.J., Yang W., et al. The contemporary role of antioxidant therapy in attenuating liver ischemia-reperfusion injury: A review. Liver Transpl 11 (2005) 1031
2. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312 (1985) 159
3. Zimmerman B.J., and Granger D.N. Mechanisms of reperfusion injury. Am J Med Sci 307 (1994) 284
4. Werns S.W., and Lucchesi B.R. Free radical and ischemic tissue injury. Trends Pharmacol Sciences 11 (1990) 161
5. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284 (2003) G15
6. Hughes H., Farhood A., and Jaeschke H. Role of leukotriene B4 in the pathogenesis of hepatic ischemia-reperfusion injury in the rat. Prostaglandins Leukot Essent Fatty Acids 45 (1992) 113
7. Ishikawa F., and Miyazaki S. New biodefense strategies by neutrophils. Arch Immunol Ther Exp (Warsz) 53 (2005) 226
8. Willerson J.T. Pharmacological approaches to reperfusion injury. Adv. Pharmacol 39 (1997) 291
9. Damtew B., Marino J.A., Fratianne R.B., et al. Neutrophil lipoxygenase metabolism and adhesive function following acute thermal injury. J Lab Clin Med 121 (1993) 328
10. Wallace J.L., Beck P.L., and Morris G.P. Is there a role for leukotrienes as mediators of ethanol-induced gastric mucosal damage?. Am J Physiol 254 (1988) G117
11. Konturek S.J., Brozozowski T., Drozdowicz D., et al. Role of leukotrienes in acute gastric lesions induced by ethanol, taurocholate, aspirin, platelet-activating factor, and stress in rats. Dig Dis Sci 33 (1988) 806
12. Holma R., Salmenperä P., Virtanen I., et al. Prophylactic potential of montelukast against mild colitis induced by dextran sulphate sodium in rats. J Physiol Pharmacol 58 (2007) 455
13. Şener G., Kabasakal L., Çetinel S., et al. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs. Burns 31 (2005) 587
14. Şener G., Şehirli O., Çetinel S., et al. Amelioration of sepsis-induced hepatic and ileal injury in rats by the leukotriene receptor blocker montelukast. Prostoglandins Leukot Essent Fatty Acids 73 (2005) 453
15. Sener G., Sehirli O., Toklu H., et al. Montelukast reduces ischaemia/reperfusion-induced bladder dysfunction and oxidant damage in the rat. J Pharm Pharmacol 59 (2007) 837
16. Sener G., Sehirli O., Velioǧlu-Oǧünç A., et al. Montelukast protects against renal ischemia/reperfusion injury in rats. Pharmacol Res 54 (2006) 65
17. Moss D.W., Henderson A.R., and Kachmar J.F. Enzymes. In: Tietz N.W. (Ed). Fundamentals of clinical chemistry (1987), WB Saunders Company, Philadelphia 372-373
18. Martinek R.G. A rapid ultraviolent spectrophotometric lactic dehydrogenase assay. Clin Chem Acta 40 (1972) 91
19. Ohara Y., Peterson T.E., and Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 92 (1993) 2546
20. Davies G.R., Simmonds N.J., Stevens T.R., et al. Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 35 (1994) 179
21. Beuge J.A., and Aust S.D. Microsomal lipid peroxidation. Methods Enzymol 52 (1978) 302
22. Beutler E. Glutathione in red blood cell metabolism. A manual of biochemical methods (1975), Grune and Stratton, New York 112-114
23. Hillegass L.M., Griswold D.E., Brickson B., et al. Assessment of myeloperoxidase activity in whole rat kidney. J Pharmacol Methods 24 (1990) 285
24. Atkinson A., Gatenby A.D., and Lowe A.G. The determination of inorganic orthophosphate in biological systems. Biochimica et Biophysica Acta 320 (1973) 195
25. Reading H.W., and Isbir T. The role of cation activated ATPase in transmitter release from the rat iris. Q J Exp Physiol 65 (1980) 105
26. Fiske C.H., and Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 66 (1925) 375
27. Lowry O.H., Rosenbrough N.J., Farr A.L., et al. Protein measurements with the folin phenol reagent. J Biol Chem 193 (1951) 265
28. Galaris D., Barbouti A., and Korantzopoulos P. Oxidative stress in hepatic ischemia-reperfusion injury: The role of antioxidants and iron chelating compounds. Curr Pharm Design 12 (2006) 2875
29. Husted T.L., and Lentsch A.B. The role of cytokines in pharmacological modulation of hepatic ischemia/reperfusion injury. Curr Pharm Design 12 (2006) 2867
30. Clavien P.A., Yadav S., Sindram D., et al. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 232 (2000) 155
31. Garcia-Criado F.J., Toledo-Pereyra L.H., Lopez-Neblina F., et al. Role of Pselectin in total hepatic ischemia and reperfusion. J Am Coll Surg 181 (1995) 327
32. Shiota N., Shimoura K., and Okunishi H. Pathophysiological role of mast cells in collagen-induced arthritis: Study with a cysteinyl leukotriene receptor antagonist, montelukast. Eur J Pharmacol 548 (2006) 158
33. Dulundu E., Ozel Y., Topaloglu U., et al. Alpha-lipoic acid protects against hepatic ischemia-reperfusion injury in rats. Pharmacology 79 (2007) 163
34. Park S.W., and Lee S.M. Antioxidant and prooxidant properties of ascorbic acid on hepatic dysfunction induced by cold ischemia/reperfusion. Eur J Pharmacol 580 (2008) 401
35. Jaeschke H. The therapeutic potential of glutathione in hepatic ischemia-reperfusion injury. Transplantation 56 (1993) 256
36. Wang J., Mochizuki H., Todokoro M., et al. Does leukotriene affect intracellular glutathione redox state in cultured human air way epithelial cells?. Antioxid Redox Signal 10 (2008) 821
37. Dengiz G.O., Odabasoglu F., Halici Z., et al. Gastroprotective and antioxidant effects of montelukast on indomethacin-induced gastric ulcer in rats. J Pharmacol Sci 105 (2007) 94
38. Jaeschke H., Bautista A.P., Spolarics Z., et al. Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats. J Leukoc Biol 52 (1992) 377
39. Takamatsu Y., Shimada K., Chijiiwa K., et al. Role of leukotrienes on hepatic ischemia/reperfusion injury in rats. J Surg Res 119 (2004) 14
40. Baba T., Black K.L., Ikezaki K., et al. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats. J Cereb Blood Flow Metab 11 (1991) 638
41. Matsui N., Fukuishi N., Fukuyama Y., et al. Protective effect of the 5-lipoxygenase inhibitor ardisiaquinone A on hepatic ischemia-reperfusion injury in rats. Planta Med 71 (2005) 717
42. Souza D.G., Pinho V., Cassali G.D., et al. Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat. Eur J Pharmacol 440 (2002) 61
43. Blum H., Osbakken M.D., and Johnson Jr. R.G. Sodium flux and bioenergetics in the ischemic rat liver. Magn Reson Med 18 (1991) 348
44. Ishii K., Suita S., and Sumimoto H. Effect of verapamil on conversion of xanthine dehydrogenase to oxidase in ischemic rat liver. Res Exp Med (Berl) 190 (1990) 389